Lung Cancer Drug Opdivo Fails Clinical Trial to Expand Use

Bristol-Myers Squibb said the drug had not slowed the progression of advanced lung cancer in a test seeking approval to use it as an initial treatment.

from NYT > Health http://ift.tt/2aZ547a
via health&fitness